PRU Achieves a Global Milestone: Receives ANVISA Certificate of Good Practices in Bioavailability/Bioequivalence
PRU Achieves a Global Milestone: Receives ANVISA Certificate of Good Practices in Bioavailability/Bioequivalence
The Pharmaceutical Research Unit is proud to announce a remarkable achievement that marks a new chapter in our journey of excellence.
Successful Clinical Inspection Reinforces PRU’s Commitment to GCP Standards
Successful Clinical Inspection Reinforces PRU’s Commitment to GCP Standards
PRU Achieves Landmark Milestone: US-FDA RRA Report Received with No Observations
PRU Achieves a Landmark Milestone: US-FDA RRA Reports Received with No Observations